Clinical Outcomes of Very Short Term Dual Antiplatelet Therapy in Patients With or Without Diabetes Undergoing Second-Generation Drug-Eluting Stents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Background: Patients with diabetes represent 20–30% of the population considered for percutaneous coronary intervention (PCI) and associate with more deleterious clinical outcome, which requires the optimal strategy of dual antiplatelet therapy (DAPT). The meta-analysis aims to compare clinical outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Xi-Ying, Li, Yan, Qiao, Xuan, Zhang, Wen-Jiao, Wang, Zhi-Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281288/
https://www.ncbi.nlm.nih.gov/pubmed/34277725
http://dx.doi.org/10.3389/fcvm.2021.655718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281288/
https://www.ncbi.nlm.nih.gov/pubmed/34277725
http://dx.doi.org/10.3389/fcvm.2021.655718

Ejemplares similares